These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 24613412)

  • 41. Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
    Carretta M; de Boer B; Jaques J; Antonelli A; Horton SJ; Yuan H; de Bruijn JD; Groen RWJ; Vellenga E; Schuringa JJ
    Exp Hematol; 2017 Jul; 51():36-46. PubMed ID: 28456746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging.
    Vick B; Rothenberg M; Sandhöfer N; Carlet M; Finkenzeller C; Krupka C; Grunert M; Trumpp A; Corbacioglu S; Ebinger M; André MC; Hiddemann W; Schneider S; Subklewe M; Metzeler KH; Spiekermann K; Jeremias I
    PLoS One; 2015; 10(3):e0120925. PubMed ID: 25793878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clonal evolution of myeloid malignancies].
    Kon A
    Rinsho Ketsueki; 2020; 61(9):1120-1129. PubMed ID: 33162507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FLT3/internal tandem duplication subclones in acute myeloid leukemia differ in their engraftment potential in NOD/SCID mice.
    Cheung AM; Chow HC; Kwong YL; Liang R; Leung AY
    Leuk Res; 2010 Jan; 34(1):119-22. PubMed ID: 19683812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.
    Krönke J; Bullinger L; Teleanu V; Tschürtz F; Gaidzik VI; Kühn MW; Rücker FG; Holzmann K; Paschka P; Kapp-Schwörer S; Späth D; Kindler T; Schittenhelm M; Krauter J; Ganser A; Göhring G; Schlegelberger B; Schlenk RF; Döhner H; Döhner K
    Blood; 2013 Jul; 122(1):100-8. PubMed ID: 23704090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How to establish acute myeloid leukemia xenograft models using immunodeficient mice.
    Shan WL; Ma XL
    Asian Pac J Cancer Prev; 2013; 14(12):7057-63. PubMed ID: 24460250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell-lineage level-targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes.
    Yokoyama K; Shimizu E; Yokoyama N; Nakamura S; Kasajima R; Ogawa M; Takei T; Ito M; Kobayashi A; Yamaguchi R; Imoto S; Miyano S; Tojo A
    Blood Adv; 2018 Oct; 2(19):2513-2521. PubMed ID: 30282643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genomic tools in acute myeloid leukemia: From the bench to the bedside.
    White BS; DiPersio JF
    Cancer; 2014 Apr; 120(8):1134-44. PubMed ID: 24474533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic heterogeneity in acute leukemia.
    Paulsson K
    Cytogenet Genome Res; 2013; 139(3):174-80. PubMed ID: 23363651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
    Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M
    J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment.
    Calleja A; Yun S; Moreilhon C; Karsenti JM; Gastaud L; Mannone L; Komrokji R; Al Ali N; Dadone-Montaudie B; Robert G; Auberger P; Raynaud S; Sallman DA; Cluzeau T
    Eur J Haematol; 2020 May; 104(5):488-498. PubMed ID: 31990086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
    Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
    Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms.
    Celik H; Krug E; Zhang CR; Han W; Issa N; Koh WK; Bjeije H; Kukhar O; Allen M; Li T; Fisher DAC; Fowles JS; Wong TN; Stubbs MC; Koblish HK; Oh ST; Challen GA
    Cancer Discov; 2021 Dec; 11(12):3126-3141. PubMed ID: 34193440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics.
    Pellegrino M; Sciambi A; Treusch S; Durruthy-Durruthy R; Gokhale K; Jacob J; Chen TX; Geis JA; Oldham W; Matthews J; Kantarjian H; Futreal PA; Patel K; Jones KW; Takahashi K; Eastburn DJ
    Genome Res; 2018 Sep; 28(9):1345-1352. PubMed ID: 30087104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia.
    Ojamies PN; Kontro M; Edgren H; Ellonen P; Lagström S; Almusa H; Miettinen T; Eldfors S; Tamborero D; Wennerberg K; Heckman C; Porkka K; Wolf M; Kallioniemi O
    Leukemia; 2017 May; 31(5):1048-1058. PubMed ID: 27795554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia.
    Carrabba MG; Tavel L; Oliveira G; Forcina A; Quilici G; Nardelli F; Tresoldi C; Ambrosi A; Ciceri F; Bernardi M; Vago L; Musco G
    J Hematol Oncol; 2016 Oct; 9(1):115. PubMed ID: 27793157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia.
    Poglio S; Lewandowski D; Calvo J; Caye A; Gros A; Laharanne E; Leblanc T; Landman-Parker J; Baruchel A; Soulier J; Ballerini P; Clappier E; Pflumio F
    Oncotarget; 2016 Jul; 7(27):41599-41611. PubMed ID: 27191650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lineage switch in childhood leukemia with monosomy 7 and reverse of lineage switch in severe combined immunodeficient mice.
    Fujisaki H; Hara J; Takai K; Nakanishi K; Matsuda Y; Ohta H; Osugi Y; Tokimasa S; Taniike M; Hosoi G; Sako M; Okada S
    Exp Hematol; 1999 May; 27(5):826-33. PubMed ID: 10340398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of mutational status and biological characteristics of acute myeloid leukemia on xenotransplantation outcomes in NOD SCID gamma mice.
    Culen M; Kosarova Z; Jeziskova I; Folta A; Chovancova J; Loja T; Tom N; Bystry V; Janeckova V; Dvorakova D; Mayer J; Racil Z
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1239-1251. PubMed ID: 29721667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease.
    Risueño RM; Campbell CJ; Dingwall S; Levadoux-Martin M; Leber B; Xenocostas A; Bhatia M
    Blood; 2011 Jun; 117(26):7112-20. PubMed ID: 21562049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.